Loading…
Loading…
IDRA (Idera Pharmaceuticals, Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
IDRA does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for IDRA and 80,000+ other tickers.
See exactly how IDRA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for IDRA and 80,000+ other tickers.
Idera Pharmaceuticals, Inc. is a biopharmaceutical company committed to the research, development, and commercialization of medicines addressing rare diseases within the United States. A key offering is Tilsotolimod (IMO-2125), a proprietary synthetic phosphorothioate oligonucleotide. This compound functions as a direct TLR9 agonist, designed to stimulate the immune system to combat solid tumors, specifically targeting head and neck squamous cell carcinoma and colorectal cancer. The firm also holds a strategic collaboration agreement with Bristol-Myers Squibb. Founded in 1989, Idera Pharmaceuticals, Inc. is headquartered in Exton, Pennsylvania.
ABU DHABI, United Arab Emirates--(BUSINESS WIRE)--At the 2024 IDRA World Congress show this week, Energy Recovery, Inc. (Nasdaq: ERII) was honored with The Breakthrough Innovation Award for Most Innovative Company in Desalination Technology. The award, announced at the IDRA World Congress Gala Dinner, “recognizes the pioneering efforts and transformative impact of a company, utility, or agency at the forefront of desalination technology.” Energy Recovery has been the trusted gold standard in en.
What you need to know about trading penny stocks right now The post Buying Penny Stocks Right Now? 3 Top Tips to Know appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Are these three penny stocks on your watchlist right now? The post 3 Penny Stocks That Are Climbing During Today's Market Selloff appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Idera Pharmaceuticals Inc (NASDAQ: IDRA) shared positive interim results from its investigator-sponsored Phase 2 trial, INTRIM 1, involving tilsotolimod, Idera's synthetic Toll-like receptor 9 agonist. Based on these results, the trial has been stopped early.
Top penny stocks to watch under $1 in April if you like Biotech stocks. The post 5 Top Biotech Penny Stocks Under $1 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.